It also functions as a tumour-suppressive miRNA targeting NOTCH2, inhibiting the epithelial-mesenchymal transition (EMT) progression of oesophageal squamous cell carcinoma (ESCC) [31]. Here, NOTCH2 is linked to esophageal squamous cell carcinoma.